Five deaths resulting from abuse of dextromethorphan sold over the internet.
Barry K Logan, Gary Goldfogel, Rebecca Hamilton, James Kuhlman
Journal of analytical toxicology March 1, 2009 DOI: 10.1093/jat/33.2.99 via PubMed
Summary
AI-generated from the abstractFive teenage males in three states died after intentionally ingesting large, recreational doses of dextromethorphan, a common over-the-counter cough suppressant that can cause intoxication, hallucinations, and dissociation at high doses. All obtained the drug from the same internet supplier. Postmortem blood concentrations ranged from 950 to 3230 ng/mL, far above therapeutic levels. Three also had diphenhydramine, one a trace of alprazolam, and two tested positive for cannabinoids. Each death was attributed to dextromethorphan toxicity or combined drug toxicity. The article describes the drug's metabolism, pharmacology, and interaction risks, and notes that the deaths led to prosecution of three individuals involved in selling or distributing the drug.
Study at a glance
| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 5 |
| Population | Teenage males who died from dextromethorphan toxicity |
| Intervention | Dextromethorphan |
| Key finding | Recreational ingestion of large doses of dextromethorphan, obtained from a common internet supplier, caused fatal toxicity in five teenage males. |
Abstract
Dextromethorphan is a widely available over-the-counter antitussive that produces intoxicating, hallucinogenic, and dissociative effects at doses significantly exceeding the therapeutic range. We report the deaths of five teenage males in three incidents in three states (WA, FL, and VA) who purposefully ingested large doses of dextromethorphan for recreational purposes and died as a result of the direct toxic effects of the drug. The dextromethorphan was obtained from the same internet supplier in each case. Postmortem blood dextromethorphan concentrations ranged from 950 to 3230 ng/mL (median 1890 ng/mL). Three subjects had diphenhydramine present, one had a trace of alprazolam, and two were positive for cannabinoids. In each case, the death was attributed to dextromethorphan toxicity or toxicity from dextromethorphan and other drugs. The article discusses the metabolism, pharmacology, and potential for drug interactions for dextromethorphan and the likely mechanisms for toxicity. The dextromethorphan concentrations in all five subjects significantly exceeded the therapeutic range and are consistent with concentrations reported in other cases of dextromethorphan abuse and toxicity. The deaths resulted in the prosecution of three individuals involved in sale or distribution of the drug.